ORIC vs. ENOV

Last updated Jun 4, 2026

ORIC (ORIC Pharmaceuticals, Inc.) and ENOV (Enovis Corp) are both stocks. ORIC operates in Biotechnology (Healthcare), while ENOV operates in Specialty Industrial Machinery (Industrials). Over the past 5 years, ORIC returned -16.59%/yr vs -22.84%/yr for ENOV. At a 0.20 correlation, their price movements are largely independent.

Performance

ORIC vs. ENOV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ORIC Pharmaceuticals, Inc. (ORIC) and Enovis Corp (ENOV). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ORIC achieves a -4.16% return, which is significantly higher than ENOV's -19.07% return.

ORIC

• 1D: 2.89%
• 1M: -18.59%
• YTD: -4.16%
• 6M: -28.60%
• 1Y: -6.67%
• 3Y*: 13.80%
• 5Y*: -16.59%
• 10Y*: —

ENOV

• 1D: -1.73%
• 1M: -7.63%
• YTD: -19.07%
• 6M: -26.37%
• 1Y: -29.73%
• 3Y*: -27.36%
• 5Y*: -22.84%
• 10Y*: -7.79%

*Multi-year figures are annualized to reflect compound growth (CAGR)

ORIC vs. ENOV - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
ORIC ORIC Pharmaceuticals, Inc.	-4.16%	1.36%	-12.28%	56.20%	-59.93%	-56.57%	31.35%
ENOV Enovis Corp	-19.07%	-39.29%	-21.67%	4.67%	-32.36%	20.21%	65.47%

Correlation

The correlation between ORIC and ENOV is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.15
Correlation (3Y) Calculated over the trailing 3-year period	0.23
Correlation (5Y) Calculated over the trailing 5-year period	0.23
Correlation (All Time) Calculated using the full available price history since Apr 27, 2020	0.20

Fundamentals

EPS ORIC : -$1.46 ENOV : -$26.70
Total Revenue (TTM) ORIC : $0.00 ENOV : $2.28B
Gross Profit (TTM) ORIC : -$320.00K ENOV : $1.38B
EBITDA (TTM) ORIC : -$140.86M ENOV : -$840.37M

Return for Risk

ORIC vs. ENOV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ORIC

ORIC Risk / Return Rank: 39
ORIC Sharpe Ratio Rank: 38
ORIC Sortino Ratio Rank: 42
ORIC Omega Ratio Rank: 44
ORIC Calmar Ratio Rank: 37
ORIC Martin Ratio Rank: 36

ENOV

ENOV Risk / Return Rank: 17
ENOV Sharpe Ratio Rank: 17
ENOV Sortino Ratio Rank: 19
ENOV Omega Ratio Rank: 20
ENOV Calmar Ratio Rank: 14
ENOV Martin Ratio Rank: 16

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ORIC vs. ENOV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ORIC Pharmaceuticals, Inc. (ORIC) and Enovis Corp (ENOV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ORIC	ENOV	Difference
Sharpe ratio: Return per unit of total volatility	-0.08	-0.55	+0.47
Sortino ratio: Return per unit of downside risk	0.48	-0.53	+1.01
Omega ratio: Gain probability vs. loss probability	1.07	0.94	+0.14
Calmar ratio: Return relative to maximum drawdown	-0.14	-0.74	+0.60
Martin ratio: Return relative to average drawdown	-0.29	-1.17	+0.89
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ORIC vs. ENOV - Sharpe Ratio Comparison

The current ORIC Sharpe Ratio is -0.08, which is higher than the ENOV Sharpe Ratio of -0.55. The chart below compares the historical Sharpe Ratios of ORIC and ENOV, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	ORIC	ENOV	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.08	-0.55	+0.47
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.19	-0.59	+0.41
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	-0.18	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.20	-0.06	-0.14

Drawdowns

ORIC vs. ENOV - Drawdown Comparison

The maximum ORIC drawdown since its inception was -93.87%, which is greater than ENOV's maximum drawdown of -83.36%. Use the drawdown chart below to compare losses from any high point for ORIC and ENOV.

Drawdown Indicators

	ORIC	ENOV	Difference
Max Drawdown Largest peak-to-trough decline	-93.87%	-83.36%	-10.51%
Max Drawdown (1Y) Largest decline over 1 year	-48.13%	-40.29%	-7.84%
Max Drawdown (3Y) Largest decline over 3 years	-73.46%	-67.26%	-6.20%
Max Drawdown (5Y) Largest decline over 5 years	-90.33%	-76.46%	-13.87%
Max Drawdown (10Y) Largest decline over 10 years	—	-76.46%	—
Current Drawdown Current decline from peak	-80.30%	-83.28%	+2.98%
Average Drawdown Average peak-to-trough decline	-67.74%	-45.92%	-21.82%
Ulcer Index Depth and duration of drawdowns from previous peaks	23.26%	25.34%	-2.08%

Volatility

ORIC vs. ENOV - Volatility Comparison

ORIC Pharmaceuticals, Inc. (ORIC) has a higher volatility of 20.73% compared to Enovis Corp (ENOV) at 19.66%. This indicates that ORIC's price experiences larger fluctuations and is considered to be riskier than ENOV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ORIC	ENOV	Difference
Volatility (1M) Calculated over the trailing 1-month period	20.73%	19.66%	+1.07%
Volatility (6M) Calculated over the trailing 6-month period	75.71%	39.94%	+35.77%
Volatility (1Y) Calculated over the trailing 1-year period	80.12%	54.08%	+26.04%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	90.08%	38.61%	+51.47%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	88.10%	42.30%	+45.80%

Dividends

ORIC vs. ENOV - Dividend Comparison

Neither ORIC nor ENOV has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both ORIC and ENOV in my portfolio?

ORIC and ENOV have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ORIC or ENOV?

ORIC has higher volatility (20.73%) compared to ENOV (19.66%). In terms of maximum drawdown, ORIC dropped -93.87% vs ENOV's -83.36%.

Which has better risk-adjusted returns?

ORIC currently has the higher Sharpe Ratio (-0.08 vs -0.55), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.